Following the announcement of 7 July 2017, NIREUS AQUACULTURE SA, informs the investing public that it received from its shareholders Piraeus Bank, Alpha Bank, Eurobank and the National Bank the following notification:

'The abovementioned banks have today signed a sale and purchase agreement for the sale of their total shares, namely 74,34%, with the acquiring company being Andromeda Seafood Limited, a member of the Andromeda Group.

Andromeda Group is the fastest growing group of companies in the Mediterranean Aquaculture. With 6 strategic centers located in Greece and Spain, it is a leader in more than 25 key markets. The Andromeda Group presently employs 640 people (270 in Spain and 370 in Greece). It has a vertically integrated production of juveniles, farming, packaging, processed and distribution of fish. The main species that the Andromeda Group produces are sea bream, sea bass and pagrus. Having managed to dynamically develop since its initial establishment until today a long with the support of Amerra Capital Management LLC, Andromeda has grown into a strong group of companies aiming at positioning itself as a major player in the global aquaculture. Mubadala Investment Company will also be participating in the acquirer's formation, being a joint shareholder with AMERRA Capital Management LLC of the Andromeda Group.

AMERRA is an independent private equity management company that provides strategic capital to companies of the Agricultural Economy in both Europe and America. AMERRA is supported by long-term institutional capital with assets under management in excess of US $ 2 billion and has invested in more than $ 3,5 billion from its establishment in 2009.

Mubadala invests on a global basis and actively manages a diverse portfolio, delivering sustainable return to its shareholder, the Abu Dhabi government. Mubadala's $ 127 billion portfolio is spread over four continents, with priority sectors being aerospace, information and communications technologies, semiconductors, metals and mining, renewable energy, oil and gas, petrochemicals, businesses public utilities, health, property, defense services, pharmaceutical and medical technology, agro-industry and a global portfolio of financial investment holdings.

The total purchase price amounts to € 10 million. The agreement provides that the investor will contribute to the company with capital while reducing the level of the company's borrowings which currently amount to € 176 million, by € 20 million with an equivalent repayment.

The transfer of shares is subject to customary conventions, and particularly to the approval by the respective authorities on acquisition audits.

The specific transaction is expected to have a positive impact on the company, in its position in the global market as well as in its cash flows.

The four systemic banks participate in the share capital of NIREUS as follows:

Group Piraeus Bank

32,23%

94.766.845

AlphaBank

20,48%

60.207.070

Eurobank Ergasias

15,50%

45.577.428

National Bank of Greece

6,13%

18.017.816

Lazard, PwC and Alvarez & Marsal have acted as financial advisors, and the law firm Koutalidi as their legal consultants of the seller .'

Attachments

  • Original document
  • Permalink

Disclaimer

Nireus SA published this content on 21 June 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 21 June 2018 08:47:05 UTC